Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 213

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 213
---
, calculated using the Black-Scholes model.

Debt issuance and offering
costs are amortized over the contractual term of the Convertible Notes, to the consolidated statements of operations in accordance with
ASC 835-30-45-1A.

The convertible notes are
subsequently recorded at amortized cost, with interest expense recognized using the effective interest method. The derivative liability,
if any is remeasured at fair value at each reporting date and any gain or loss on fair value is recognized in the statement of comprehensive
income.

Promissory notes, originated
from ASCA’s transaction and being taken over by NewGenIVF Group Limited upon merger, are of non-interest bearing and recorded at
original cost. They are subsequently measured at amortised cost, with interest expense recognized using the effective interest method
in the consolidated statement of income.

<div align='center'>F-14</div>

The Company’s ordinary
shares are stated at no par value. The difference between the consideration received, net of issuance cost, is recorded in additional
paid-in capital.

On January 21, 2025, the
Board of Directors of the Company approved a reverse stock split of all of the Company’s issued and unissued shares, including
the Class A ordinary shares with no par value (the “Class A Ordinary Shares”), Class B ordinary shares with no par value
and preferred shares with no par value, at an exchange ratio of one (1) share for twenty (20) shares (the “Reverse Stock Split”).
Upon the opening of the market on February 11, 2025, the Company’s Class A Ordinary Shares will begin trading on the Nasdaq Global
Market (“Nasdaq”) on a post-Reverse Stock Split basis.

On April 15, 2025, the Board
of Directors of the Company approved a reverse stock split of all of the Company’s issued and unissued shares, including the Class
A ordinary shares with no par value (the “Class A Ordinary Shares”), Class B ordinary shares with no par value and preferred
shares with no par value, at an exchange ratio of one (1) share for ten (10) shares (the “Reverse Stock Split”). Upon the
opening of the market on May 5, 2025, the Company’s Class A Ordinary Shares began trading on the Nasdaq Capital Market (“Nasdaq”)
on a post-Reverse Stock Split basis.

In accordance with ASC 505,
the reverse stock split is to be